Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared a paper he and his colleagues authored on LinkedIn:
“Trials on adjuvant endocrine therapy for luminal breast cancer agree on only one thing: that it improves patient outcome. But which is the optimal strategy? In our comprehensive network meta-analysis and analysis of reconstructed individual patient data, the third part of a collaboration between Karolinska Institutet and Vall d’Hebron Institute of Oncology (VHIO), published today at eClinicalMedicine – The Lancet Discovery Science (IF: 9.6) we aim to answer this question.
Thank you to all collaborators: Andri Papakonstantinou, Guillermo Villacampa, Víctor Navarro Garcés, Antonios Valachis, Mafalda Oliveira, Tomás Pascual Martínez.”
Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis
Authors: Andri Papakonstantinou et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023